|
A Diabetes Literacy Board, consisting of experts in cardiology, endocrinology, diabetes education and health literacy, has been launched with funding from pharmaceutical giant GlaxoSmithKline.
The board intends to raise public awareness and understanding of type 2 diabetes by developing educational materials for patients and families. The materials will address symptoms, risk factors and long-term complications of type 2 diabetes and insulin resistance.
In type 2 diabetes, the body loses its ability to properly use the hormone insulin, which regulates blood sugar. Although most common among older adults, the increasing prevalence of obesity and overweight among younger Americans has caused type 2 diabetes to increase among this group.
It is estimated that 17 million Americans have diabetes, however according to a 2001 survey of over 500 adults with type 2 diabetes, half of the participants didn't understand the disease or its potentially serious long-term complications, which include heart disease, blindness, kidney failure and nerve damage.
A past study has also found a link between low health literacy and poor blood-sugar control in patients with type 2 diabetes.
Health literacy is often defined as the degree to which individuals obtain, process and understand basic health information needed to make appropriate health decisions. Understanding the fundamentals of type 2 diabetes management may help improve health outcomes.
One expert noted that diabetes management can be complicated since it involves meal planning, physical activity, blood sugar monitoring, and often medication. In order to manage the condition effectively, health literacy is essential.
Aside from being the fifth leading cause of death from disease, diabetes is also one of the most costly health problems in America. In 2002, diabetes costs were estimated at $132 billion.
Glaxo Smith Kline May 12, 2003
|